Global Ofatumumab Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Analog Vacuum Regulator
- Digital Vacuum Regulator
- Clinically
- Surgical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ohio Medical
- Amico
- Precision Medical
- Air Liquid Healthcare
- Integral
- Allied Healthcare Products
- Shanghai Amcaremed Technology
- Acare
- Hersill
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ofatumumab Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Ofatumumab by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Ofatumumab by Country/Region, 2020, 2024 & 2031
2.2 Ofatumumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Ofatumumab Sales by Type
2.3.1 Global Ofatumumab Sales Market Share by Type (2020-2025)
2.3.2 Global Ofatumumab Revenue and Market Share by Type (2020-2025)
2.3.3 Global Ofatumumab Sale Price by Type (2020-2025)
2.4 Ofatumumab Segment by Application
2.4.1 Chemical
2.4.2 Pharmaceutical
2.5 Ofatumumab Sales by Application
2.5.1 Global Ofatumumab Sale Market Share by Application (2020-2025)
2.5.2 Global Ofatumumab Revenue and Market Share by Application (2020-2025)
2.5.3 Global Ofatumumab Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Ofatumumab Breakdown Data by Company
3.1.1 Global Ofatumumab Annual Sales by Company (2020-2025)
3.1.2 Global Ofatumumab Sales Market Share by Company (2020-2025)
3.2 Global Ofatumumab Annual Revenue by Company (2020-2025)
3.2.1 Global Ofatumumab Revenue by Company (2020-2025)
3.2.2 Global Ofatumumab Revenue Market Share by Company (2020-2025)
3.3 Global Ofatumumab Sale Price by Company
3.4 Key Manufacturers Ofatumumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ofatumumab Product Location Distribution
3.4.2 Players Ofatumumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OFATUMUMAB BY GEOGRAPHIC REGION
4.1 World Historic Ofatumumab Market Size by Geographic Region (2020-2025)
4.1.1 Global Ofatumumab Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Ofatumumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ofatumumab Market Size by Country/Region (2020-2025)
4.2.1 Global Ofatumumab Annual Sales by Country/Region (2020-2025)
4.2.2 Global Ofatumumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ofatumumab Sales Growth
4.4 APAC Ofatumumab Sales Growth
4.5 Europe Ofatumumab Sales Growth
4.6 Middle East & Africa Ofatumumab Sales Growth
5 AMERICAS
5.1 Americas Ofatumumab Sales by Country
5.1.1 Americas Ofatumumab Sales by Country (2020-2025)
5.1.2 Americas Ofatumumab Revenue by Country (2020-2025)
5.2 Americas Ofatumumab Sales by Type (2020-2025)
5.3 Americas Ofatumumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ofatumumab Sales by Region
6.1.1 APAC Ofatumumab Sales by Region (2020-2025)
6.1.2 APAC Ofatumumab Revenue by Region (2020-2025)
6.2 APAC Ofatumumab Sales by Type (2020-2025)
6.3 APAC Ofatumumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ofatumumab by Country
7.1.1 Europe Ofatumumab Sales by Country (2020-2025)
7.1.2 Europe Ofatumumab Revenue by Country (2020-2025)
7.2 Europe Ofatumumab Sales by Type (2020-2025)
7.3 Europe Ofatumumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ofatumumab by Country
8.1.1 Middle East & Africa Ofatumumab Sales by Country (2020-2025)
8.1.2 Middle East & Africa Ofatumumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Ofatumumab Sales by Type (2020-2025)
8.3 Middle East & Africa Ofatumumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ofatumumab
10.3 Manufacturing Process Analysis of Ofatumumab
10.4 Industry Chain Structure of Ofatumumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ofatumumab Distributors
11.3 Ofatumumab Customer
12 WORLD FORECAST REVIEW FOR OFATUMUMAB BY GEOGRAPHIC REGION
12.1 Global Ofatumumab Market Size Forecast by Region
12.1.1 Global Ofatumumab Forecast by Region (2026-2031)
12.1.2 Global Ofatumumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ofatumumab Forecast by Type (2026-2031)
12.7 Global Ofatumumab Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BOC Sciences
13.1.1 BOC Sciences Company Information
13.1.2 BOC Sciences Ofatumumab Product Portfolios and Specifications
13.1.3 BOC Sciences Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BOC Sciences Main Business Overview
13.1.5 BOC Sciences Latest Developments
13.2 GlaxoSmithKline(GSK)
13.2.1 GlaxoSmithKline(GSK) Company Information
13.2.2 GlaxoSmithKline(GSK) Ofatumumab Product Portfolios and Specifications
13.2.3 GlaxoSmithKline(GSK) Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline(GSK) Main Business Overview
13.2.5 GlaxoSmithKline(GSK) Latest Developments
13.3 Lonza Group
13.3.1 Lonza Group Company Information
13.3.2 Lonza Group Ofatumumab Product Portfolios and Specifications
13.3.3 Lonza Group Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lonza Group Main Business Overview
13.3.5 Lonza Group Latest Developments
13.4 Novartis International
13.4.1 Novartis International Company Information
13.4.2 Novartis International Ofatumumab Product Portfolios and Specifications
13.4.3 Novartis International Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis International Main Business Overview
13.4.5 Novartis International Latest Developments
13.5 TargetMol Chemicals
13.5.1 TargetMol Chemicals Company Information
13.5.2 TargetMol Chemicals Ofatumumab Product Portfolios and Specifications
13.5.3 TargetMol Chemicals Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 TargetMol Chemicals Main Business Overview
13.5.5 TargetMol Chemicals Latest Developments
13.6 Hubei Kele Fine Chemical
13.6.1 Hubei Kele Fine Chemical Company Information
13.6.2 Hubei Kele Fine Chemical Ofatumumab Product Portfolios and Specifications
13.6.3 Hubei Kele Fine Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hubei Kele Fine Chemical Main Business Overview
13.6.5 Hubei Kele Fine Chemical Latest Developments
13.7 Jiangxi Ruiweier Biotechnology
13.7.1 Jiangxi Ruiweier Biotechnology Company Information
13.7.2 Jiangxi Ruiweier Biotechnology Ofatumumab Product Portfolios and Specifications
13.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jiangxi Ruiweier Biotechnology Main Business Overview
13.7.5 Jiangxi Ruiweier Biotechnology Latest Developments
13.8 Nantong Feiyu Biological Technology
13.8.1 Nantong Feiyu Biological Technology Company Information
13.8.2 Nantong Feiyu Biological Technology Ofatumumab Product Portfolios and Specifications
13.8.3 Nantong Feiyu Biological Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nantong Feiyu Biological Technology Main Business Overview
13.8.5 Nantong Feiyu Biological Technology Latest Developments
13.9 Shanghai Biochempartner
13.9.1 Shanghai Biochempartner Company Information
13.9.2 Shanghai Biochempartner Ofatumumab Product Portfolios and Specifications
13.9.3 Shanghai Biochempartner Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai Biochempartner Main Business Overview
13.9.5 Shanghai Biochempartner Latest Developments
13.10 Shanghai Macklin Biochemical
13.10.1 Shanghai Macklin Biochemical Company Information
13.10.2 Shanghai Macklin Biochemical Ofatumumab Product Portfolios and Specifications
13.10.3 Shanghai Macklin Biochemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai Macklin Biochemical Main Business Overview
13.10.5 Shanghai Macklin Biochemical Latest Developments
13.11 Shanghai Yifei Biotechnology
13.11.1 Shanghai Yifei Biotechnology Company Information
13.11.2 Shanghai Yifei Biotechnology Ofatumumab Product Portfolios and Specifications
13.11.3 Shanghai Yifei Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shanghai Yifei Biotechnology Main Business Overview
13.11.5 Shanghai Yifei Biotechnology Latest Developments
13.12 Tianmen Hengchang Chemical
13.12.1 Tianmen Hengchang Chemical Company Information
13.12.2 Tianmen Hengchang Chemical Ofatumumab Product Portfolios and Specifications
13.12.3 Tianmen Hengchang Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Tianmen Hengchang Chemical Main Business Overview
13.12.5 Tianmen Hengchang Chemical Latest Developments
13.13 Wuhan Topule Biopharmaceutical
13.13.1 Wuhan Topule Biopharmaceutical Company Information
13.13.2 Wuhan Topule Biopharmaceutical Ofatumumab Product Portfolios and Specifications
13.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuhan Topule Biopharmaceutical Main Business Overview
13.13.5 Wuhan Topule Biopharmaceutical Latest Developments
13.14 Wuhan Wogeda Biotechnology
13.14.1 Wuhan Wogeda Biotechnology Company Information
13.14.2 Wuhan Wogeda Biotechnology Ofatumumab Product Portfolios and Specifications
13.14.3 Wuhan Wogeda Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Wuhan Wogeda Biotechnology Main Business Overview
13.14.5 Wuhan Wogeda Biotechnology Latest Developments
13.15 Wuhan Yingnuo Pharmaceutical Technology
13.15.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
13.15.2 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Portfolios and Specifications
13.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview
13.15.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ofatumumab Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Ofatumumab by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Ofatumumab by Country/Region, 2020, 2024 & 2031
2.2 Ofatumumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Ofatumumab Sales by Type
2.3.1 Global Ofatumumab Sales Market Share by Type (2020-2025)
2.3.2 Global Ofatumumab Revenue and Market Share by Type (2020-2025)
2.3.3 Global Ofatumumab Sale Price by Type (2020-2025)
2.4 Ofatumumab Segment by Application
2.4.1 Chemical
2.4.2 Pharmaceutical
2.5 Ofatumumab Sales by Application
2.5.1 Global Ofatumumab Sale Market Share by Application (2020-2025)
2.5.2 Global Ofatumumab Revenue and Market Share by Application (2020-2025)
2.5.3 Global Ofatumumab Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Ofatumumab Breakdown Data by Company
3.1.1 Global Ofatumumab Annual Sales by Company (2020-2025)
3.1.2 Global Ofatumumab Sales Market Share by Company (2020-2025)
3.2 Global Ofatumumab Annual Revenue by Company (2020-2025)
3.2.1 Global Ofatumumab Revenue by Company (2020-2025)
3.2.2 Global Ofatumumab Revenue Market Share by Company (2020-2025)
3.3 Global Ofatumumab Sale Price by Company
3.4 Key Manufacturers Ofatumumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ofatumumab Product Location Distribution
3.4.2 Players Ofatumumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OFATUMUMAB BY GEOGRAPHIC REGION
4.1 World Historic Ofatumumab Market Size by Geographic Region (2020-2025)
4.1.1 Global Ofatumumab Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Ofatumumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ofatumumab Market Size by Country/Region (2020-2025)
4.2.1 Global Ofatumumab Annual Sales by Country/Region (2020-2025)
4.2.2 Global Ofatumumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ofatumumab Sales Growth
4.4 APAC Ofatumumab Sales Growth
4.5 Europe Ofatumumab Sales Growth
4.6 Middle East & Africa Ofatumumab Sales Growth
5 AMERICAS
5.1 Americas Ofatumumab Sales by Country
5.1.1 Americas Ofatumumab Sales by Country (2020-2025)
5.1.2 Americas Ofatumumab Revenue by Country (2020-2025)
5.2 Americas Ofatumumab Sales by Type (2020-2025)
5.3 Americas Ofatumumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ofatumumab Sales by Region
6.1.1 APAC Ofatumumab Sales by Region (2020-2025)
6.1.2 APAC Ofatumumab Revenue by Region (2020-2025)
6.2 APAC Ofatumumab Sales by Type (2020-2025)
6.3 APAC Ofatumumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ofatumumab by Country
7.1.1 Europe Ofatumumab Sales by Country (2020-2025)
7.1.2 Europe Ofatumumab Revenue by Country (2020-2025)
7.2 Europe Ofatumumab Sales by Type (2020-2025)
7.3 Europe Ofatumumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ofatumumab by Country
8.1.1 Middle East & Africa Ofatumumab Sales by Country (2020-2025)
8.1.2 Middle East & Africa Ofatumumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Ofatumumab Sales by Type (2020-2025)
8.3 Middle East & Africa Ofatumumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ofatumumab
10.3 Manufacturing Process Analysis of Ofatumumab
10.4 Industry Chain Structure of Ofatumumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ofatumumab Distributors
11.3 Ofatumumab Customer
12 WORLD FORECAST REVIEW FOR OFATUMUMAB BY GEOGRAPHIC REGION
12.1 Global Ofatumumab Market Size Forecast by Region
12.1.1 Global Ofatumumab Forecast by Region (2026-2031)
12.1.2 Global Ofatumumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ofatumumab Forecast by Type (2026-2031)
12.7 Global Ofatumumab Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BOC Sciences
13.1.1 BOC Sciences Company Information
13.1.2 BOC Sciences Ofatumumab Product Portfolios and Specifications
13.1.3 BOC Sciences Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BOC Sciences Main Business Overview
13.1.5 BOC Sciences Latest Developments
13.2 GlaxoSmithKline(GSK)
13.2.1 GlaxoSmithKline(GSK) Company Information
13.2.2 GlaxoSmithKline(GSK) Ofatumumab Product Portfolios and Specifications
13.2.3 GlaxoSmithKline(GSK) Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline(GSK) Main Business Overview
13.2.5 GlaxoSmithKline(GSK) Latest Developments
13.3 Lonza Group
13.3.1 Lonza Group Company Information
13.3.2 Lonza Group Ofatumumab Product Portfolios and Specifications
13.3.3 Lonza Group Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lonza Group Main Business Overview
13.3.5 Lonza Group Latest Developments
13.4 Novartis International
13.4.1 Novartis International Company Information
13.4.2 Novartis International Ofatumumab Product Portfolios and Specifications
13.4.3 Novartis International Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis International Main Business Overview
13.4.5 Novartis International Latest Developments
13.5 TargetMol Chemicals
13.5.1 TargetMol Chemicals Company Information
13.5.2 TargetMol Chemicals Ofatumumab Product Portfolios and Specifications
13.5.3 TargetMol Chemicals Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 TargetMol Chemicals Main Business Overview
13.5.5 TargetMol Chemicals Latest Developments
13.6 Hubei Kele Fine Chemical
13.6.1 Hubei Kele Fine Chemical Company Information
13.6.2 Hubei Kele Fine Chemical Ofatumumab Product Portfolios and Specifications
13.6.3 Hubei Kele Fine Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hubei Kele Fine Chemical Main Business Overview
13.6.5 Hubei Kele Fine Chemical Latest Developments
13.7 Jiangxi Ruiweier Biotechnology
13.7.1 Jiangxi Ruiweier Biotechnology Company Information
13.7.2 Jiangxi Ruiweier Biotechnology Ofatumumab Product Portfolios and Specifications
13.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jiangxi Ruiweier Biotechnology Main Business Overview
13.7.5 Jiangxi Ruiweier Biotechnology Latest Developments
13.8 Nantong Feiyu Biological Technology
13.8.1 Nantong Feiyu Biological Technology Company Information
13.8.2 Nantong Feiyu Biological Technology Ofatumumab Product Portfolios and Specifications
13.8.3 Nantong Feiyu Biological Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nantong Feiyu Biological Technology Main Business Overview
13.8.5 Nantong Feiyu Biological Technology Latest Developments
13.9 Shanghai Biochempartner
13.9.1 Shanghai Biochempartner Company Information
13.9.2 Shanghai Biochempartner Ofatumumab Product Portfolios and Specifications
13.9.3 Shanghai Biochempartner Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai Biochempartner Main Business Overview
13.9.5 Shanghai Biochempartner Latest Developments
13.10 Shanghai Macklin Biochemical
13.10.1 Shanghai Macklin Biochemical Company Information
13.10.2 Shanghai Macklin Biochemical Ofatumumab Product Portfolios and Specifications
13.10.3 Shanghai Macklin Biochemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai Macklin Biochemical Main Business Overview
13.10.5 Shanghai Macklin Biochemical Latest Developments
13.11 Shanghai Yifei Biotechnology
13.11.1 Shanghai Yifei Biotechnology Company Information
13.11.2 Shanghai Yifei Biotechnology Ofatumumab Product Portfolios and Specifications
13.11.3 Shanghai Yifei Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shanghai Yifei Biotechnology Main Business Overview
13.11.5 Shanghai Yifei Biotechnology Latest Developments
13.12 Tianmen Hengchang Chemical
13.12.1 Tianmen Hengchang Chemical Company Information
13.12.2 Tianmen Hengchang Chemical Ofatumumab Product Portfolios and Specifications
13.12.3 Tianmen Hengchang Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Tianmen Hengchang Chemical Main Business Overview
13.12.5 Tianmen Hengchang Chemical Latest Developments
13.13 Wuhan Topule Biopharmaceutical
13.13.1 Wuhan Topule Biopharmaceutical Company Information
13.13.2 Wuhan Topule Biopharmaceutical Ofatumumab Product Portfolios and Specifications
13.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuhan Topule Biopharmaceutical Main Business Overview
13.13.5 Wuhan Topule Biopharmaceutical Latest Developments
13.14 Wuhan Wogeda Biotechnology
13.14.1 Wuhan Wogeda Biotechnology Company Information
13.14.2 Wuhan Wogeda Biotechnology Ofatumumab Product Portfolios and Specifications
13.14.3 Wuhan Wogeda Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Wuhan Wogeda Biotechnology Main Business Overview
13.14.5 Wuhan Wogeda Biotechnology Latest Developments
13.15 Wuhan Yingnuo Pharmaceutical Technology
13.15.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
13.15.2 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Portfolios and Specifications
13.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview
13.15.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ofatumumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Ofatumumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 6. Global Ofatumumab Sales Market Share by Type (2020-2025)
Table 7. Global Ofatumumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Ofatumumab Revenue Market Share by Type (2020-2025)
Table 9. Global Ofatumumab Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Ofatumumab Sale by Application (2020-2025) & (Kg)
Table 11. Global Ofatumumab Sale Market Share by Application (2020-2025)
Table 12. Global Ofatumumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Ofatumumab Revenue Market Share by Application (2020-2025)
Table 14. Global Ofatumumab Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Ofatumumab Sales by Company (2020-2025) & (Kg)
Table 16. Global Ofatumumab Sales Market Share by Company (2020-2025)
Table 17. Global Ofatumumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Ofatumumab Revenue Market Share by Company (2020-2025)
Table 19. Global Ofatumumab Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Ofatumumab Producing Area Distribution and Sales Area
Table 21. Players Ofatumumab Products Offered
Table 22. Ofatumumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ofatumumab Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Ofatumumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Ofatumumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Ofatumumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Ofatumumab Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Ofatumumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Ofatumumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Ofatumumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 34. Americas Ofatumumab Sales Market Share by Country (2020-2025)
Table 35. Americas Ofatumumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 37. Americas Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 38. APAC Ofatumumab Sales by Region (2020-2025) & (Kg)
Table 39. APAC Ofatumumab Sales Market Share by Region (2020-2025)
Table 40. APAC Ofatumumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 42. APAC Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 43. Europe Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 44. Europe Ofatumumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 46. Europe Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Ofatumumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Ofatumumab
Table 52. Key Market Challenges & Risks of Ofatumumab
Table 53. Key Industry Trends of Ofatumumab
Table 54. Ofatumumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ofatumumab Distributors List
Table 57. Ofatumumab Customer List
Table 58. Global Ofatumumab Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Ofatumumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Ofatumumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Ofatumumab Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Ofatumumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Ofatumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Ofatumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Ofatumumab Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Ofatumumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Ofatumumab Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Ofatumumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. BOC Sciences Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 73. BOC Sciences Ofatumumab Product Portfolios and Specifications
Table 74. BOC Sciences Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. BOC Sciences Main Business
Table 76. BOC Sciences Latest Developments
Table 77. GlaxoSmithKline(GSK) Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline(GSK) Ofatumumab Product Portfolios and Specifications
Table 79. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline(GSK) Main Business
Table 81. GlaxoSmithKline(GSK) Latest Developments
Table 82. Lonza Group Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 83. Lonza Group Ofatumumab Product Portfolios and Specifications
Table 84. Lonza Group Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Lonza Group Main Business
Table 86. Lonza Group Latest Developments
Table 87. Novartis International Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis International Ofatumumab Product Portfolios and Specifications
Table 89. Novartis International Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Novartis International Main Business
Table 91. Novartis International Latest Developments
Table 92.TargetMol Chemicals Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 93.TargetMol Chemicals Ofatumumab Product Portfolios and Specifications
Table 94.TargetMol Chemicals Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95.TargetMol Chemicals Main Business
Table 96.TargetMol Chemicals Latest Developments
Table 97. Hubei KeleFine Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Hubei KeleFine Chemical Ofatumumab Product Portfolios and Specifications
Table 99. Hubei KeleFine Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Hubei KeleFine Chemical Main Business
Table 101. Hubei KeleFine Chemical Latest Developments
Table 102. Jiangxi Ruiweier Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangxi Ruiweier Biotechnology Ofatumumab Product Portfolios and Specifications
Table 104. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Jiangxi Ruiweier Biotechnology Main Business
Table 106. Jiangxi Ruiweier Biotechnology Latest Developments
Table 107. Nantong Feiyu Biological Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Nantong Feiyu Biological Technology Ofatumumab Product Portfolios and Specifications
Table 109. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Nantong Feiyu Biological Technology Main Business
Table 111. Nantong Feiyu Biological Technology Latest Developments
Table 112. Shanghai Biochempartner Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai Biochempartner Ofatumumab Product Portfolios and Specifications
Table 114. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Shanghai Biochempartner Main Business
Table 116. Shanghai Biochempartner Latest Developments
Table 117. Shanghai Macklin Biochemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Macklin Biochemical Ofatumumab Product Portfolios and Specifications
Table 119. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Shanghai Macklin Biochemical Main Business
Table 121. Shanghai Macklin Biochemical Latest Developments
Table 122. Shanghai Yifei Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Yifei Biotechnology Ofatumumab Product Portfolios and Specifications
Table 124. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Shanghai Yifei Biotechnology Main Business
Table 126. Shanghai Yifei Biotechnology Latest Developments
Table 127. Tianmen Hengchang Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Tianmen Hengchang Chemical Ofatumumab Product Portfolios and Specifications
Table 129. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Tianmen Hengchang Chemical Main Business
Table 131. Tianmen Hengchang Chemical Latest Developments
Table 132. Wuhan Topule Biopharmaceutical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Wuhan Topule Biopharmaceutical Ofatumumab Product Portfolios and Specifications
Table 134. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Wuhan Topule Biopharmaceutical Main Business
Table 136. Wuhan Topule Biopharmaceutical Latest Developments
Table 137. Wuhan Wogeda Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 138. Wuhan Wogeda Biotechnology Ofatumumab Product Portfolios and Specifications
Table 139. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 140. Wuhan Wogeda Biotechnology Main Business
Table 141. Wuhan Wogeda Biotechnology Latest Developments
Table 142. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 143. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Portfolios and Specifications
Table 144. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 145. Wuhan Yingnuo Pharmaceutical Technology Main Business
Table 146. Wuhan Yingnuo Pharmaceutical Technology Latest Developments
Table 1. Ofatumumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Ofatumumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 6. Global Ofatumumab Sales Market Share by Type (2020-2025)
Table 7. Global Ofatumumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Ofatumumab Revenue Market Share by Type (2020-2025)
Table 9. Global Ofatumumab Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Ofatumumab Sale by Application (2020-2025) & (Kg)
Table 11. Global Ofatumumab Sale Market Share by Application (2020-2025)
Table 12. Global Ofatumumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Ofatumumab Revenue Market Share by Application (2020-2025)
Table 14. Global Ofatumumab Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Ofatumumab Sales by Company (2020-2025) & (Kg)
Table 16. Global Ofatumumab Sales Market Share by Company (2020-2025)
Table 17. Global Ofatumumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Ofatumumab Revenue Market Share by Company (2020-2025)
Table 19. Global Ofatumumab Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Ofatumumab Producing Area Distribution and Sales Area
Table 21. Players Ofatumumab Products Offered
Table 22. Ofatumumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ofatumumab Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Ofatumumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Ofatumumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Ofatumumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Ofatumumab Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Ofatumumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Ofatumumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Ofatumumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 34. Americas Ofatumumab Sales Market Share by Country (2020-2025)
Table 35. Americas Ofatumumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 37. Americas Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 38. APAC Ofatumumab Sales by Region (2020-2025) & (Kg)
Table 39. APAC Ofatumumab Sales Market Share by Region (2020-2025)
Table 40. APAC Ofatumumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 42. APAC Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 43. Europe Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 44. Europe Ofatumumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 46. Europe Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Ofatumumab Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Ofatumumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Ofatumumab Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Ofatumumab Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Ofatumumab
Table 52. Key Market Challenges & Risks of Ofatumumab
Table 53. Key Industry Trends of Ofatumumab
Table 54. Ofatumumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ofatumumab Distributors List
Table 57. Ofatumumab Customer List
Table 58. Global Ofatumumab Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Ofatumumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Ofatumumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Ofatumumab Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Ofatumumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Ofatumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Ofatumumab Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Ofatumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Ofatumumab Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Ofatumumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Ofatumumab Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Ofatumumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. BOC Sciences Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 73. BOC Sciences Ofatumumab Product Portfolios and Specifications
Table 74. BOC Sciences Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. BOC Sciences Main Business
Table 76. BOC Sciences Latest Developments
Table 77. GlaxoSmithKline(GSK) Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline(GSK) Ofatumumab Product Portfolios and Specifications
Table 79. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline(GSK) Main Business
Table 81. GlaxoSmithKline(GSK) Latest Developments
Table 82. Lonza Group Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 83. Lonza Group Ofatumumab Product Portfolios and Specifications
Table 84. Lonza Group Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Lonza Group Main Business
Table 86. Lonza Group Latest Developments
Table 87. Novartis International Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis International Ofatumumab Product Portfolios and Specifications
Table 89. Novartis International Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Novartis International Main Business
Table 91. Novartis International Latest Developments
Table 92.TargetMol Chemicals Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 93.TargetMol Chemicals Ofatumumab Product Portfolios and Specifications
Table 94.TargetMol Chemicals Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95.TargetMol Chemicals Main Business
Table 96.TargetMol Chemicals Latest Developments
Table 97. Hubei KeleFine Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Hubei KeleFine Chemical Ofatumumab Product Portfolios and Specifications
Table 99. Hubei KeleFine Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Hubei KeleFine Chemical Main Business
Table 101. Hubei KeleFine Chemical Latest Developments
Table 102. Jiangxi Ruiweier Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangxi Ruiweier Biotechnology Ofatumumab Product Portfolios and Specifications
Table 104. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Jiangxi Ruiweier Biotechnology Main Business
Table 106. Jiangxi Ruiweier Biotechnology Latest Developments
Table 107. Nantong Feiyu Biological Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Nantong Feiyu Biological Technology Ofatumumab Product Portfolios and Specifications
Table 109. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Nantong Feiyu Biological Technology Main Business
Table 111. Nantong Feiyu Biological Technology Latest Developments
Table 112. Shanghai Biochempartner Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai Biochempartner Ofatumumab Product Portfolios and Specifications
Table 114. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Shanghai Biochempartner Main Business
Table 116. Shanghai Biochempartner Latest Developments
Table 117. Shanghai Macklin Biochemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Macklin Biochemical Ofatumumab Product Portfolios and Specifications
Table 119. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Shanghai Macklin Biochemical Main Business
Table 121. Shanghai Macklin Biochemical Latest Developments
Table 122. Shanghai Yifei Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Yifei Biotechnology Ofatumumab Product Portfolios and Specifications
Table 124. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Shanghai Yifei Biotechnology Main Business
Table 126. Shanghai Yifei Biotechnology Latest Developments
Table 127. Tianmen Hengchang Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Tianmen Hengchang Chemical Ofatumumab Product Portfolios and Specifications
Table 129. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Tianmen Hengchang Chemical Main Business
Table 131. Tianmen Hengchang Chemical Latest Developments
Table 132. Wuhan Topule Biopharmaceutical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Wuhan Topule Biopharmaceutical Ofatumumab Product Portfolios and Specifications
Table 134. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Wuhan Topule Biopharmaceutical Main Business
Table 136. Wuhan Topule Biopharmaceutical Latest Developments
Table 137. Wuhan Wogeda Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 138. Wuhan Wogeda Biotechnology Ofatumumab Product Portfolios and Specifications
Table 139. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 140. Wuhan Wogeda Biotechnology Main Business
Table 141. Wuhan Wogeda Biotechnology Latest Developments
Table 142. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
Table 143. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Portfolios and Specifications
Table 144. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 145. Wuhan Yingnuo Pharmaceutical Technology Main Business
Table 146. Wuhan Yingnuo Pharmaceutical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ofatumumab
Figure 2. Ofatumumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ofatumumab Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Ofatumumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Ofatumumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Ofatumumab Sales Market Share by Country/Region (2024)
Figure 10. Ofatumumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Patent
Figure 12. Product Picture of Generic
Figure 13. Global Ofatumumab Sales Market Share by Type in 2025
Figure 14. Global Ofatumumab Revenue Market Share by Type (2020-2025)
Figure 15. Ofatumumab Consumed in Chemical
Figure 16. Global Ofatumumab Market: Chemical (2020-2025) & (Kg)
Figure 17. Ofatumumab Consumed in Pharmaceutical
Figure 18. Global Ofatumumab Market: Pharmaceutical (2020-2025) & (Kg)
Figure 19. Global Ofatumumab Sale Market Share by Application (2024)
Figure 20. Global Ofatumumab Revenue Market Share by Application in 2025
Figure 21. Ofatumumab Sales by Company in 2025 (Kg)
Figure 22. Global Ofatumumab Sales Market Share by Company in 2025
Figure 23. Ofatumumab Revenue by Company in 2025 ($ millions)
Figure 24. Global Ofatumumab Revenue Market Share by Company in 2025
Figure 25. Global Ofatumumab Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Ofatumumab Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Ofatumumab Sales 2020-2025 (Kg)
Figure 28. Americas Ofatumumab Revenue 2020-2025 ($ millions)
Figure 29. APAC Ofatumumab Sales 2020-2025 (Kg)
Figure 30. APAC Ofatumumab Revenue 2020-2025 ($ millions)
Figure 31. Europe Ofatumumab Sales 2020-2025 (Kg)
Figure 32. Europe Ofatumumab Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Ofatumumab Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Ofatumumab Revenue 2020-2025 ($ millions)
Figure 35. Americas Ofatumumab Sales Market Share by Country in 2025
Figure 36. Americas Ofatumumab Revenue Market Share by Country (2020-2025)
Figure 37. Americas Ofatumumab Sales Market Share by Type (2020-2025)
Figure 38. Americas Ofatumumab Sales Market Share by Application (2020-2025)
Figure 39. United States Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Ofatumumab Sales Market Share by Region in 2025
Figure 44. APAC Ofatumumab Revenue Market Share by Region (2020-2025)
Figure 45. APAC Ofatumumab Sales Market Share by Type (2020-2025)
Figure 46. APAC Ofatumumab Sales Market Share by Application (2020-2025)
Figure 47. China Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 51. India Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Ofatumumab Sales Market Share by Country in 2025
Figure 55. Europe Ofatumumab Revenue Market Share by Country (2020-2025)
Figure 56. Europe Ofatumumab Sales Market Share by Type (2020-2025)
Figure 57. Europe Ofatumumab Sales Market Share by Application (2020-2025)
Figure 58. Germany Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 59. France Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Ofatumumab Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Ofatumumab Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Ofatumumab Sales Market Share by Application (2020-2025)
Figure 66. Egypt Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Ofatumumab in 2025
Figure 72. Manufacturing Process Analysis of Ofatumumab
Figure 73. Industry Chain Structure of Ofatumumab
Figure 74. Channels of Distribution
Figure 75. Global Ofatumumab Sales Market Forecast by Region (2026-2031)
Figure 76. Global Ofatumumab Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Ofatumumab Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Ofatumumab Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Ofatumumab Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Ofatumumab Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Ofatumumab
Figure 2. Ofatumumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ofatumumab Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Ofatumumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Ofatumumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Ofatumumab Sales Market Share by Country/Region (2024)
Figure 10. Ofatumumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Patent
Figure 12. Product Picture of Generic
Figure 13. Global Ofatumumab Sales Market Share by Type in 2025
Figure 14. Global Ofatumumab Revenue Market Share by Type (2020-2025)
Figure 15. Ofatumumab Consumed in Chemical
Figure 16. Global Ofatumumab Market: Chemical (2020-2025) & (Kg)
Figure 17. Ofatumumab Consumed in Pharmaceutical
Figure 18. Global Ofatumumab Market: Pharmaceutical (2020-2025) & (Kg)
Figure 19. Global Ofatumumab Sale Market Share by Application (2024)
Figure 20. Global Ofatumumab Revenue Market Share by Application in 2025
Figure 21. Ofatumumab Sales by Company in 2025 (Kg)
Figure 22. Global Ofatumumab Sales Market Share by Company in 2025
Figure 23. Ofatumumab Revenue by Company in 2025 ($ millions)
Figure 24. Global Ofatumumab Revenue Market Share by Company in 2025
Figure 25. Global Ofatumumab Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Ofatumumab Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Ofatumumab Sales 2020-2025 (Kg)
Figure 28. Americas Ofatumumab Revenue 2020-2025 ($ millions)
Figure 29. APAC Ofatumumab Sales 2020-2025 (Kg)
Figure 30. APAC Ofatumumab Revenue 2020-2025 ($ millions)
Figure 31. Europe Ofatumumab Sales 2020-2025 (Kg)
Figure 32. Europe Ofatumumab Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Ofatumumab Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Ofatumumab Revenue 2020-2025 ($ millions)
Figure 35. Americas Ofatumumab Sales Market Share by Country in 2025
Figure 36. Americas Ofatumumab Revenue Market Share by Country (2020-2025)
Figure 37. Americas Ofatumumab Sales Market Share by Type (2020-2025)
Figure 38. Americas Ofatumumab Sales Market Share by Application (2020-2025)
Figure 39. United States Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Ofatumumab Sales Market Share by Region in 2025
Figure 44. APAC Ofatumumab Revenue Market Share by Region (2020-2025)
Figure 45. APAC Ofatumumab Sales Market Share by Type (2020-2025)
Figure 46. APAC Ofatumumab Sales Market Share by Application (2020-2025)
Figure 47. China Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 51. India Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Ofatumumab Sales Market Share by Country in 2025
Figure 55. Europe Ofatumumab Revenue Market Share by Country (2020-2025)
Figure 56. Europe Ofatumumab Sales Market Share by Type (2020-2025)
Figure 57. Europe Ofatumumab Sales Market Share by Application (2020-2025)
Figure 58. Germany Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 59. France Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Ofatumumab Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Ofatumumab Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Ofatumumab Sales Market Share by Application (2020-2025)
Figure 66. Egypt Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Ofatumumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Ofatumumab in 2025
Figure 72. Manufacturing Process Analysis of Ofatumumab
Figure 73. Industry Chain Structure of Ofatumumab
Figure 74. Channels of Distribution
Figure 75. Global Ofatumumab Sales Market Forecast by Region (2026-2031)
Figure 76. Global Ofatumumab Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Ofatumumab Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Ofatumumab Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Ofatumumab Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Ofatumumab Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Grip Test Activity Monitors Market Growth 2023-2029
US$ 3,660.00
March 2023
107 pages
Global Coronary Vascular Closure Devices Market Growth 2023-2029
US$ 3,660.00
March 2023
102 pages
Global Recombinant Coagulation Factors Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
89 pages
Global 3D Bioprinter and Bioink Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Desynchronosis Treatment Market Growth 2024-2030
US$ 3,660.00
March 2024
106 pages
